Application of Silver Nanoparticles in Cancer Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 136
Special Issue Editors
Interests: nano-oncology; nano-drug delivery; protein nanocages; breast cancer; nano-tracers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite the enormous progress made in recent years in terms of research and therapies, cancer continues to be one of the most insidious challenges of modern medicine. Features such as multidrug resistance, recurrence, migration, invasion, and the ability to evade the host's immune system are among the main causes that make the majority of conventional treatments ineffective. To deal with these problems, innovative therapeutic methods have been developed, such as immunotherapy, gene therapy, and the use of metal nanoparticles. Among metal nanoparticles, silver nanoparticles (SNs) are attracting a lot of interest thanks to their anticancer properties, the ability to enhance the efficacy of treatments such as radiotherapy or phototherapy, and the possibility of being used in combination with other nanoparticles. Furthermore, properties such as plasmon resonance make SNs interesting diagnostic tools.
This Special Issue aims to highlight and collect research articles and reviews focused on the use of silver nanoparticles for the treatment and diagnosis of cancer.
We are pleased to invite researchers to contribute their original work or reviews concerning the synthesis and characterization of innovative anticancer SNs, in vitro and in vivo application of SNs, and clinical trials and studies focused on the application of SNs as diagnostic and theranostic tools.
Dr. Serena Mazzucchelli
Dr. Francesco Ragonese
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- silver nanoparticles
- nanomedicine
- nanotechnology
- cancer therapy
- cancer diagnostics
- cancer theranostics
- tumor targeting
- drug delivery systems
- in vitro studies
- in vivo studies
